These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 23376148)

  • 1. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
    Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
    J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
    Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
    J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease.
    Gelbard M; Lipshultz LI; Tursi J; Smith T; Kaufman G; Levine LA
    J Urol; 2012 Jun; 187(6):2268-74. PubMed ID: 22503048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
    Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
    J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
    Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
    J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety Profile of Collagenase Clostridium Histolyticum Stratified by Degree of Penile Curvature in Patients With Peyronie Disease.
    Hellstrom WJG; Tan RBW; Liu G
    Urology; 2017 Aug; 106():237.e9-237.e14. PubMed ID: 28502596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study.
    Cocci A; Russo GI; Salonia A; Cito G; Regis F; Polloni G; Giubilei G; Cacciamani G; Capece M; Falcone M; Greco I; Timpano M; Minervini A; Gacci M; Cai T; Garaffa G; Giammusso B; Arcaniolo D; Mirone V; Mondaini N
    J Sex Med; 2018 May; 15(5):716-721. PubMed ID: 29699756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
    Levine LA; Larsen SM
    J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Collagenase Clostridium histolyticum (Xiapex
    Cocci A; Di Maida F; Russo GI; Capogrosso P; Francesco L; Rizzo M; Di Mauro M; Salonia A; Cito G; Falcone M; Romano A; Polloni G; Martinez-Salamanca JI; Fernández-Pascual E; Minervini A; Mondaini N
    Clin Drug Investig; 2020 Jun; 40(6):583-588. PubMed ID: 32342279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
    Ralph DJ; Abdel Raheem A; Liu G
    J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies.
    Lipshultz LI; Goldstein I; Seftel AD; Kaufman GJ; Smith TM; Tursi JP; Burnett AL
    BJU Int; 2015 Oct; 116(4):650-6. PubMed ID: 25711400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
    Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
    J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagenase Clostridium Histolyticum: A Review in Peyronie's Disease.
    Dhillon S
    Drugs; 2015 Aug; 75(12):1405-12. PubMed ID: 26201462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Curvature Improvement in Men With Peyronie's Disease Treated With Intralesional Collagenase Clostridium Histolyticum.
    Flores JM; Nascimento B; Punjani N; Salter CA; Bernie HL; Taniguchi H; Miranda E; Terrier JE; Schofield E; Jenkins L; Mulhall JP
    J Sex Med; 2022 Nov; 19(11):1680-1686. PubMed ID: 36127227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
    Abdel Raheem A; Ralph D
    Eur Urol; 2014 Jan; 65(1):251-2. PubMed ID: 24289857
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification.
    Goldstein I; McLane MP; Xiang Q; Wolfe HR; Hu Y; Gelbard MK
    Urology; 2020 Dec; 146():145-151. PubMed ID: 32896582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies.
    Hellstrom WJ; Feldman RA; Coyne KS; Kaufman GJ; Smith TM; Tursi JP; Rosen RC
    Urology; 2015 Aug; 86(2):291-8. PubMed ID: 26199168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie's disease (PD).
    Carson CC; Sadeghi-Nejad H; Tursi JP; Smith TM; Kaufman GJ; Gilbert K; Honig SC
    BJU Int; 2015 Nov; 116(5):815-22. PubMed ID: 25818264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sixty years in the making: collagenase Clostridium histolyticum, from benchtop to FDA approval and beyond.
    Mills SA; Gelbard MK
    World J Urol; 2020 Feb; 38(2):269-277. PubMed ID: 31168744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline characteristics from an ongoing phase 3 study of collagenase clostridium histolyticum in patients with Peyronie's disease.
    Gelbard M; Hellstrom WJ; McMahon CG; Levine LA; Smith T; Tursi J; Kaufman G; Goldstein I
    J Sex Med; 2013 Nov; 10(11):2822-31. PubMed ID: 24112401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.